Cargando…
Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
Background Potential Drug–Drug Interactions (DDI) account for many emergency department visits. Polypharmacy, as well as herbal, over-the-counter (OTC) and combination medication may compound this, but these problems are not well researched in low-and-middle-income countries. Objective To compare th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686268/ https://www.ncbi.nlm.nih.gov/pubmed/28795285 http://dx.doi.org/10.1007/s11096-017-0520-9 |
_version_ | 1783278758742982656 |
---|---|
author | Dookeeram, Darren Bidaisee, Satesh Paul, Joanne F. Nunes, Paula Robertson, Paula Maharaj, Vidya Ramcharitar Sammy, Ian |
author_facet | Dookeeram, Darren Bidaisee, Satesh Paul, Joanne F. Nunes, Paula Robertson, Paula Maharaj, Vidya Ramcharitar Sammy, Ian |
author_sort | Dookeeram, Darren |
collection | PubMed |
description | Background Potential Drug–Drug Interactions (DDI) account for many emergency department visits. Polypharmacy, as well as herbal, over-the-counter (OTC) and combination medication may compound this, but these problems are not well researched in low-and-middle-income countries. Objective To compare the incidence of drug–drug interactions and polypharmacy in older and younger patients attending the Emergency Department (ED). Setting The adult ED of a tertiary teaching hospital in Trinidad. Methods A 4 month cross sectional study was conducted, comparing potential DDI in older and younger patients discharged from the ED, as defined using Micromedex 2.0. Main outcome measure The incidence and severity of DDI and polypharmacy (defined as the use of ≥5 drugs simultaneously) in older and younger patients attending the ED. Results 649 patients were included; 275 (42.3%) were ≥65 years and 381 (58.7%) were female. There were 814 DDIs, of which 6 (.7%) were contraindications and 148 (18.2%) were severe. Polypharmacy was identified in 244 (37.6%) patients. Older patients were more likely to have potential DDI (67.5 vs 48.9%) and polypharmacy (56 vs 24.1%). Herbal products, OTC and combination drugs were present in 8, 36.7 and 22.2% of patients, respectively. On multivariate analysis, polypharmacy and the presence of hypertension and ischaemic heart disease were associated with an increased risk of potential DDI. Conclusion Polypharmacy and potential drug–drug interactions are common in ED patients in the Caribbean. Older patients are particularly at risk, especially as they are more likely to be on multiple medications. The association between herbal medication and polypharmacy needs further investigation. This study indicates the need for a more robust system of drug reconciliation in the Caribbean. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11096-017-0520-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5686268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-56862682017-11-28 Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean Dookeeram, Darren Bidaisee, Satesh Paul, Joanne F. Nunes, Paula Robertson, Paula Maharaj, Vidya Ramcharitar Sammy, Ian Int J Clin Pharm Research Article Background Potential Drug–Drug Interactions (DDI) account for many emergency department visits. Polypharmacy, as well as herbal, over-the-counter (OTC) and combination medication may compound this, but these problems are not well researched in low-and-middle-income countries. Objective To compare the incidence of drug–drug interactions and polypharmacy in older and younger patients attending the Emergency Department (ED). Setting The adult ED of a tertiary teaching hospital in Trinidad. Methods A 4 month cross sectional study was conducted, comparing potential DDI in older and younger patients discharged from the ED, as defined using Micromedex 2.0. Main outcome measure The incidence and severity of DDI and polypharmacy (defined as the use of ≥5 drugs simultaneously) in older and younger patients attending the ED. Results 649 patients were included; 275 (42.3%) were ≥65 years and 381 (58.7%) were female. There were 814 DDIs, of which 6 (.7%) were contraindications and 148 (18.2%) were severe. Polypharmacy was identified in 244 (37.6%) patients. Older patients were more likely to have potential DDI (67.5 vs 48.9%) and polypharmacy (56 vs 24.1%). Herbal products, OTC and combination drugs were present in 8, 36.7 and 22.2% of patients, respectively. On multivariate analysis, polypharmacy and the presence of hypertension and ischaemic heart disease were associated with an increased risk of potential DDI. Conclusion Polypharmacy and potential drug–drug interactions are common in ED patients in the Caribbean. Older patients are particularly at risk, especially as they are more likely to be on multiple medications. The association between herbal medication and polypharmacy needs further investigation. This study indicates the need for a more robust system of drug reconciliation in the Caribbean. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11096-017-0520-9) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-08-09 2017 /pmc/articles/PMC5686268/ /pubmed/28795285 http://dx.doi.org/10.1007/s11096-017-0520-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Article Dookeeram, Darren Bidaisee, Satesh Paul, Joanne F. Nunes, Paula Robertson, Paula Maharaj, Vidya Ramcharitar Sammy, Ian Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean |
title | Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean |
title_full | Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean |
title_fullStr | Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean |
title_full_unstemmed | Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean |
title_short | Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean |
title_sort | polypharmacy and potential drug–drug interactions in emergency department patients in the caribbean |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686268/ https://www.ncbi.nlm.nih.gov/pubmed/28795285 http://dx.doi.org/10.1007/s11096-017-0520-9 |
work_keys_str_mv | AT dookeeramdarren polypharmacyandpotentialdrugdruginteractionsinemergencydepartmentpatientsinthecaribbean AT bidaiseesatesh polypharmacyandpotentialdrugdruginteractionsinemergencydepartmentpatientsinthecaribbean AT pauljoannef polypharmacyandpotentialdrugdruginteractionsinemergencydepartmentpatientsinthecaribbean AT nunespaula polypharmacyandpotentialdrugdruginteractionsinemergencydepartmentpatientsinthecaribbean AT robertsonpaula polypharmacyandpotentialdrugdruginteractionsinemergencydepartmentpatientsinthecaribbean AT maharajvidyaramcharitar polypharmacyandpotentialdrugdruginteractionsinemergencydepartmentpatientsinthecaribbean AT sammyian polypharmacyandpotentialdrugdruginteractionsinemergencydepartmentpatientsinthecaribbean |